cover image
89bio

89bio

www.89bio.com

1 Job

143 Employees

About the Company

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). Recent Phase 1b/2a data show BIO89-100 demonstrated a favorable safety and tolerability profile and robust reductions in liver fat and key lipid markers when dosed weekly or once every two weeks in patients with NASH. BIO89-100 is currently in a Phase 2 trial for the treatment of SHTG. 89bio is headquartered in San Francisco with operations in Herzliya, Israel. Our culture is best described by our values: * Always putting the patient first * Operating with the highest integrity and ethical standards at all times * Being authentic in all our transactions * Acting as a team - collaborating, respecting and caring for one another * Being entrepreneurial and passionate in our tasks * Being scientific and rational in our thought process and decision-making

Listed Jobs

Company background Company brand
Company Name
89bio
Job Title
Director, Quality Assurance - Computerized System/Data Integrity
Job Description
**Job Title:** Director, Quality Assurance – Computerized Systems/Data Integrity **Role Summary:** Leads the quality assurance function for computerized system validation, GxP software implementation, and data‑integrity governance across the organization. Ensures all computerized systems and associated data meet global regulatory requirements throughout their lifecycle and supports regulatory inspections and audits. **Expectations:** - Provide strategic QA oversight for all GxP computerized systems. - Maintain compliance with ALCOA+ data‑integrity principles and relevant regulations. - Drive continuous improvement of the computerized‑system QMS and risk‑based validation approaches. - Serve as subject‑matter expert during inspections, audits, and cross‑functional projects. **Key Responsibilities:** - Lead validation, implementation, and lifecycle management of GxP systems (authoring URS, FRS, validation plans, protocols, scripts, reports). - Manage vendor qualification and oversight for SaaS/cloud platforms and outsourced service providers. - Establish and sustain a data‑integrity governance program across all GxP domains. - Oversee change control, periodic system reviews, gap analysis, and CAPA execution for computerized systems. - Develop, maintain, and train on SOPs related to CSV, data integrity, and software lifecycle management. - Collaborate with internal stakeholders to provide QA guidance, training, and support for system owners and business users. - Prepare and act as SME for regulatory inspections (FDA, EMA, MHRA, etc.) and sponsor/CRO audits. **Required Skills:** - Deep knowledge of 21 CFR Part 11, EU Annex 11, GAMP 5, ICH E6(R3) GCP, MHRA GxP Data Integrity Guidance, 21 CFR Parts 210/211, 820, 4. - Proven experience designing and executing risk‑based computer system validation strategies. - Strong vendor management and SaaS/cloud platform oversight capabilities. - Expertise in data‑integrity principles (ALCOA+), traceability, and audit readiness. - Excellent communication, training, and cross‑functional collaboration skills. - Ability to lead change control, perform impact assessments, and manage CAPAs. **Required Education & Certifications:** - Bachelor’s degree (or higher) in a scientific, engineering, or computer science discipline. - Minimum 10 years of QA experience in the biopharmaceutical industry, with a focus on computerized system validation and data integrity. - Relevant certifications (e.g., Certified Quality Auditor, Certified Professional in GxP, or similar) are preferred but not mandatory.
San francisco, United states
On site
Senior
24-10-2025